Target intelligence / Profile preview

Enzyme cofactor for amino acid metabolism

Molecular classification
Other (cofactors, small molecules)
01

Overview

"Enzyme cofactor for amino acid metabolism" encompasses several distinct small molecules, mainly vitamin-derived organic cofactors (such as **pyridoxal phosphate** [vitamin B6], **tetrahydrofolate** [vitamin B9], **cobalamin** [vitamin B12], and **tetrahydrobiopterin**), as well as inorganic ions, which are required for a wide variety of enzymatic steps in amino acid catabolism, biosynthesis, transamination, and one-carbon transfer reactions[1][2][3]. These cofactors are essential for stabilizing reaction intermediates, enabling electron and group transfers, and ensuring complete metabolism of amino acids for energy, biosynthesis, and waste removal. Deficiencies in these cofactors can cause serious metabolic diseases, neurological disorders, or impact cancer and cardiovascular risk through effects on methylation and amino acid homeostasis[1][2]. **Note:** This entry is too generic or broad to correspond to a single canonical therapeutic target or target class. "Enzyme cofactor for amino acid metabolism" refers to a *chemical function* rather than a protein or gene. For structured data, individual cofactors (e.g., "pyridoxal phosphate," "tetrahydrofolate") should be treated as distinct entries.

Other names
Cofactor for amino acid metabolismEnzyme cofactor (amino acid)
02

Mechanism of action

Cofactor supplementation restores or maintains enzyme activity Antifolates (e.g., methotrexate) inhibit folate-dependent enzymes Some drugs act by modulating or blocking use of specific cofactors in metabolic pathways

03

Biological functions

Amino acid metabolismEnzyme catalysisElectron transferOne-carbon transferGroup transfer
04

Disease associations

Other (Vitamin deficiencies can cause metabolic disease)Neurodegenerative disease (in context of deficiencies)Cancer (by affecting methylation via folate/vitamin B12)Inborn errors of metabolism
05

Safety considerations

Vitamin overdose or deficiency (toxicity, neuropathy)Drug–vitamin antagonism (e.g., methotrexate can cause folate deficiency)Risk of masking underlying pathology (e.g., folate supplementation masking B12 deficiency)
06

Interacting drugs

Folic acid (vitamin B9)

5 more in the full profile.

07

Biomarkers

Serum folateSerum homocysteine (accumulates with B12/folate/PLP deficiency)Vitamin B6, B12 levelsMethylmalonic acid (B12 status)Amino acid profiles in plasma/urine

Beyond the preview

Go deeper on Enzyme cofactor for amino acid metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enzyme cofactor for amino acid metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call